BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 14701702)

  • 61. Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations.
    Zhu XH; Shen YL; Jing YK; Cai X; Jia PM; Huang Y; Tang W; Shi GY; Sun YP; Dai J; Wang ZY; Chen SJ; Zhang TD; Waxman S; Chen Z; Chen GQ
    J Natl Cancer Inst; 1999 May; 91(9):772-8. PubMed ID: 10328107
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Arsenic trioxide-induced mitotic arrest and apoptosis in acute promyelocytic leukemia cells.
    Cai X; Yu Y; Huang Y; Zhang L; Jia PM; Zhao Q; Chen Z; Tong JH; Dai W; Chen GQ
    Leukemia; 2003 Jul; 17(7):1333-7. PubMed ID: 12835721
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Induction of B-chronic lymphocytic leukemia cell apoptosis by arsenic trioxide involves suppression of the phosphoinositide 3-kinase/Akt survival pathway via c-jun-NH2 terminal kinase activation and PTEN upregulation.
    Redondo-Muñoz J; Escobar-Díaz E; Hernández Del Cerro M; Pandiella A; Terol MJ; García-Marco JA; García-Pardo A
    Clin Cancer Res; 2010 Sep; 16(17):4382-91. PubMed ID: 20534739
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Arsenic trioxide sensitizes promonocytic leukemia cells to TNFalpha-induced apoptosis via p38-MAPK-regulated activation of both receptor-mediated and mitochondrial pathways.
    Amrán D; Sánchez Y; Fernández C; Ramos AM; de Blas E; Bréard J; Calle C; Aller P
    Biochim Biophys Acta; 2007 Nov; 1773(11):1653-63. PubMed ID: 17673311
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Arsenic trioxide and proteasome inhibitor bortezomib synergistically induce apoptosis in leukemic cells: the role of protein kinase Cdelta.
    Yan H; Wang YC; Li D; Wang Y; Liu W; Wu YL; Chen GQ
    Leukemia; 2007 Jul; 21(7):1488-95. PubMed ID: 17495969
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Involvement of a Rho-ROCK-JNK pathway in arsenic trioxide-induced apoptosis in chronic myelogenous leukemia cells.
    Potin S; Bertoglio J; Bréard J
    FEBS Lett; 2007 Jan; 581(1):118-24. PubMed ID: 17182041
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Combination treatment with arsenic trioxide and phytosphingosine enhances apoptotic cell death in arsenic trioxide-resistant cancer cells.
    Park MT; Kang YH; Park IC; Kim CH; Lee YS; Chung HY; Lee SJ
    Mol Cancer Ther; 2007 Jan; 6(1):82-92. PubMed ID: 17237268
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Arsenic trioxide induces apoptosis and G2/M phase arrest by inducing Cbl to inhibit PI3K/Akt signaling and thereby regulate p53 activation.
    Li Y; Qu X; Qu J; Zhang Y; Liu J; Teng Y; Hu X; Hou K; Liu Y
    Cancer Lett; 2009 Nov; 284(2):208-15. PubMed ID: 19457607
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Apoptosis induction by (+)alpha-tocopheryl succinate in the absence or presence of all-trans retinoic acid and arsenic trioxide in NB4, NB4-R2 and primary APL cells.
    Freitas RA; Silva dos Santos GA; Gimenes Teixeira HL; Scheucher PS; Lucena-Araujo AR; Lima AS; Abreu e Lima RS; Garcia AB; Jordão AA; Falcão RP; Vannucchi H; Rego EM
    Leuk Res; 2009 Jul; 33(7):958-63. PubMed ID: 19013639
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Enhancement of esculetin on arsenic trioxide-provoked apoptosis in human leukemia U937 cells.
    Lin TH; Lu FJ; Yin YF; Tseng TH
    Chem Biol Interact; 2009 Jun; 180(1):61-8. PubMed ID: 19428345
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Arsenic trioxide concentration determines the fate of Ewing's sarcoma family tumors and neuroblastoma cells in vitro.
    Jung HS; Kim HS; Lee MJ; Shin HY; Ahn HS; Ryu KH; Seoh JY; Kim CJ; Jang JJ
    FEBS Lett; 2006 Sep; 580(20):4969-75. PubMed ID: 16930595
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Potent reducing effects of vitamin D3 on the frequency of apoptosis induced by arsenic trioxide in NB4 cell line.
    Mozdarani H; Asghari F
    Arch Iran Med; 2010 Jan; 13(1):26-33. PubMed ID: 20039766
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Redistribution of cell cycle by arsenic trioxide is associated with demethylation and expression changes of cell cycle related genes in acute promyelocytic leukemia cell line (NB4).
    Hassani S; Khaleghian A; Ahmadian S; Alizadeh S; Alimoghaddam K; Ghavamzadeh A; Ghaffari SH
    Ann Hematol; 2018 Jan; 97(1):83-93. PubMed ID: 29159499
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Treatment of acute promyelocytic leukemia with arsenic compounds: in vitro and in vivo studies.
    Chen Z; Chen GQ; Shen ZX; Chen SJ; Wang ZY
    Semin Hematol; 2001 Jan; 38(1):26-36. PubMed ID: 11172537
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Death by arsenic: implications of PML sumoylation.
    Mann KK; Miller WH
    Cancer Cell; 2004 Apr; 5(4):307-9. PubMed ID: 15093537
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [In vitro study of the effects of arsenic trioxide combined with 8-CPT-cAMP on differentiation induction in retinoic acid resistant acute promyelocytic leukemia cells].
    Zhu Q; Yu Y; Jia PM; Cai X; Chen SJ; Chen Z; Wang ZY; Tong JH
    Zhonghua Xue Ye Xue Za Zhi; 2003 Jan; 24(1):6-9. PubMed ID: 12679001
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The effect of MAPK inhibitors on arsenic trioxide-treated Calu-6 lung cells in relation to cell death, ROS and GSH levels.
    Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
    Anticancer Res; 2009 Oct; 29(10):3837-44. PubMed ID: 19846917
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Characterization of arsenic-induced cytogenetic alterations in acute promyelocytic leukemia cell line, NB4.
    Yaghmaie M; Mozdarani H; Alimoghaddam K; Ghaffari SH; Ghavamzadeh A; Hajhashemi M
    Med Oncol; 2012 Jun; 29(2):1209-16. PubMed ID: 21544632
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Arsenic trioxide combined with buthionine sulfoximine enhances apoptosis in multidrug-resistant human leukemia K562/ADM cells in vitro].
    Wang T; Ma LM; Zhang HP; Wang HW; Yang LH; Qiao ZH
    Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):188-91. PubMed ID: 18756933
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Survivin isoform expression in arsenic trioxide-treated acute promyelocytic leukemia cell line and patients: The odd expression pattern of survivin-2α.
    Zaki Dizaji M; Ghaffari SH; Hosseini E; Alizadeh N; Rostami S; Momeny M; Alimoghaddam K; Ghavamzadeh A
    Asia Pac J Clin Oncol; 2017 Apr; 13(2):e21-e30. PubMed ID: 27770503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.